• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Two cases of vitiligo vulgaris treated with topical Janus kinase inhibitor delgocitinib.

作者信息

Yagi Kumi, Ishida Yoshihiro, Otsuka Atsushi, Kabashima Kenji

机构信息

Department of Dermatology, Gradute School of Medicine, Kyoto University, Kyoto, Japan.

出版信息

Australas J Dermatol. 2021 Aug;62(3):433-434. doi: 10.1111/ajd.13572. Epub 2021 Mar 5.

DOI:10.1111/ajd.13572
PMID:33667323
Abstract
摘要

相似文献

1
Two cases of vitiligo vulgaris treated with topical Janus kinase inhibitor delgocitinib.两例寻常型白癜风患者接受外用Janus激酶抑制剂地尔itinib治疗。
Australas J Dermatol. 2021 Aug;62(3):433-434. doi: 10.1111/ajd.13572. Epub 2021 Mar 5.
2
Oral tofacitinib: a promising treatment in atopic dermatitis, alopecia areata and vitiligo.口服托法替布：治疗特应性皮炎、斑秃和白癜风的一种有前景的疗法。
Clin Exp Dermatol. 2017 Dec;42(8):942-944. doi: 10.1111/ced.13290. Epub 2017 Oct 16.
3
Janus kinase inhibitor delgocitinib suppresses pruritus and nerve elongation in an atopic dermatitis murine model.Janus激酶抑制剂地尔戈替尼在特应性皮炎小鼠模型中可抑制瘙痒和神经伸长。
J Dermatol Sci. 2020 Feb;97(2):161-164. doi: 10.1016/j.jdermsci.2019.12.008. Epub 2019 Dec 20.
4
Delgocitinib ointment, a topical Janus kinase inhibitor, in adult patients with moderate to severe atopic dermatitis: A phase 3, randomized, double-blind, vehicle-controlled study and an open-label, long-term extension study.地夸磷索钠滴眼液治疗干眼病的有效性和安全性的 Meta 分析
J Am Acad Dermatol. 2020 Apr;82(4):823-831. doi: 10.1016/j.jaad.2019.12.015. Epub 2020 Feb 3.
5
Janus Kinase Inhibitors in the Treatment of Vitiligo: A Review.Janus 激酶抑制剂治疗白癜风：综述。
Front Immunol. 2021 Nov 18;12:790125. doi: 10.3389/fimmu.2021.790125. eCollection 2021.
6
Tofacitinib Citrate for the Treatment of Vitiligo: A Pathogenesis-Directed Therapy.枸橼酸托法替布治疗白癜风：一种针对发病机制的治疗方法。
JAMA Dermatol. 2015 Oct;151(10):1110-2. doi: 10.1001/jamadermatol.2015.1520.
7
Discovery of a Janus Kinase Inhibitor Bearing a Highly Three-Dimensional Spiro Scaffold: JTE-052 (Delgocitinib) as a New Dermatological Agent to Treat Inflammatory Skin Disorders.发现具有高度三维螺环支架的 Janus 激酶抑制剂：JTE-052（地洛替尼）作为一种治疗炎症性皮肤疾病的新型皮肤科药物。
J Med Chem. 2020 Jul 9;63(13):7163-7185. doi: 10.1021/acs.jmedchem.0c00450. Epub 2020 Jun 29.
8
Delgocitinib: First Approval.地夸磷索钠：美国批准
Drugs. 2020 Apr;80(6):609-615. doi: 10.1007/s40265-020-01291-2.
9
Long-term safety and efficacy of delgocitinib ointment, a topical Janus kinase inhibitor, in adult patients with atopic dermatitis.地夸磷索钠滴眼液治疗干眼的随机、双盲、安慰剂对照多中心临床试验
J Dermatol. 2020 Feb;47(2):114-120. doi: 10.1111/1346-8138.15173. Epub 2019 Dec 9.
10
JAK inhibitors for the treatment of vitiligo.JAK 抑制剂治疗白癜风。
J Dermatol Sci. 2024 Mar;113(3):86-92. doi: 10.1016/j.jdermsci.2023.12.008. Epub 2024 Jan 11.

引用本文的文献

1
Efficacy and Safety of JAK Inhibitors in the Management of Vitiligo: A Systematic Review and Meta-analysis.JAK抑制剂治疗白癜风的疗效与安全性：一项系统评价和Meta分析
Dermatol Ther (Heidelb). 2025 May 7. doi: 10.1007/s13555-025-01397-z.
2
Treatment Advances in Vitiligo: An Updated Review.白癜风的治疗进展：最新综述
Dermatol Pract Concept. 2025 Jan 30;15(1):4600. doi: 10.5826/dpc.1501a4600.
3
Efficacy and Safety of Janus Kinase Inhibitors in Patients with Vitiligo: A Systematic Review and Meta-Analysis.白癜风患者中 Janus 激酶抑制剂的疗效与安全性：一项系统评价与荟萃分析
Clin Pharmacol Ther. 2025 Mar;117(3):659-669. doi: 10.1002/cpt.3538. Epub 2024 Dec 23.
4
Role of Cytokines and Chemokines in Vitiligo and Their Therapeutic Implications.细胞因子和趋化因子在白癜风中的作用及其治疗意义
J Clin Med. 2024 Aug 20;13(16):4919. doi: 10.3390/jcm13164919.
5
Up-and-Coming Drugs for the Treatment of Vitiligo.治疗白癜风的新兴药物
Ann Dermatol. 2024 Aug;36(4):197-208. doi: 10.5021/ad.24.038.
6
Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis.JAK抑制剂治疗中度至重度斑秃的疗效和安全性比较：一项系统评价和网状Meta分析
Front Pharmacol. 2024 Apr 10;15:1372810. doi: 10.3389/fphar.2024.1372810. eCollection 2024.
7
Updates on Potential Therapeutic Approaches for Vitiligo: Janus Kinase Inhibitors and Biologics.白癜风潜在治疗方法的最新进展：Janus激酶抑制剂和生物制剂。
J Clin Med. 2023 Dec 4;12(23):7486. doi: 10.3390/jcm12237486.
8
Vitiligo, from Pathogenesis to Therapeutic Advances: State of the Art.白癜风：从发病机制到治疗进展的最新研究进展。
Int J Mol Sci. 2023 Mar 3;24(5):4910. doi: 10.3390/ijms24054910.
9
A Literature Review Investigating the Use of Topical Janus Kinase Inhibitors for the Treatment of Vitiligo.一项关于外用 Janus 激酶抑制剂治疗白癜风的文献综述
J Clin Aesthet Dermatol. 2022 Apr;15(4):20-25.